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Sandeep Salipalli, Prafull Kumar Singh and Jürgen Borlak*Abstract
Live cell imaging enables the study of dynamic processes of living cells in real time by use of suitable reporter
proteins and the staining of specific cellular structures and/or organelles. With the availability of advanced optical
devices and improved cell culture protocols it has become a rapidly growing research methodology. The success of
this technique relies mainly on the selection of suitable reporter proteins, construction of recombinant plasmids
possessing cell type specific promoters as well as reliable methods of gene transfer. This review aims to provide an
overview of the recent developments in the field of marker proteins (bioluminescence and fluorescent) and
methodologies (fluorescent resonance energy transfer, fluorescent recovery after photobleaching and proximity
ligation assay) employed as to achieve an improved imaging of biological processes in hepatoma cells. Moreover,
different expression systems of marker proteins and the modes of gene transfer are discussed with emphasis on
the study of lipid droplet formation in hepatocytes as an example.
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Lipid dropletBackground
Microscopy has contributed immensely to our under-
standing of cellular structure and morphology. However,
traditional microscopic tools provide only limited infor-
mation in terms of dynamical processes occurring in a
living cell which are of great interest for biomedical re-
searchers. Advances in optical methods, in vitro culture
systems and molecular biology led to the advent of live
cell imaging techniques. This non-invasive technique
provides better insight into the biological role of target
molecules by allowing researchers to investigate the dy-
namic processes occurring in living cells in real time.
The technique has many potential applications in vari-
ous fields of biomedical science including developmental
biology, cell biology and tumor biology and provides op-
portunity to study the dynamic behaviour of living cells in
context to gene expression, protein-protein interaction,
co-localization, cell division, chromosomal dynamics and
intracellular transport of bio-molecules. The success of
live cell imaging relies on various factors including the
specific imaging system, climate controlling devices for* Correspondence: borlak.juergen@mh-hannover.de
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unless otherwise stated.cultured cells under investigation, construction of recom-
binant plasmid DNA, transfer and expression of candidate
genes and/or fluorescent proteins in mammalian cells.
These factors greatly influence the fluorescent/biolumin-
escent signals obtained from the cultured cells. The gene
transfer methods should not only be efficient in delivery
and in ensuring stable expression but at the same time
should exert minimum toxic effects to the cultured cells.
Furthermore, the chosen fluorescent or bioluminescent
markers should be minimally phototoxic to the cells at
their highest expression levels. Amongst the biolumines-
cent markers, ATP dependent and independent luciferases
from various sources have been extensively used in im-
aging experiments [1,2]. The use of bioluminescent
markers is not only limited to in vitro assays or live cell
imaging but is also applied to in vivo molecular imaging
experiments. Various lines of luciferase expressing
transgenic mice and cells have so far been developed
and are frequently employed in biomedical research,
and a major breakthrough in the field of fluorescent
protein imaging was the discovery of Green Fluorescent
Protein (GFP) by Osamu Shimomura who received the
Nobel prize in Chemistry in 2008 together with Martin
Chalfie und Roger Tsien [3,4]. After the advent of GFPLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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derstanding the detailed and complex cellular dynamics.
Apart from GFP and its variants, many other fluorescent
proteins have been isolated from a variety of sources and
are successfully used in imaging experiments of various
cell types and their organelles. In this regard, live cell im-
aging has been employed to study functional genetics of
liver specific diseases including steatosis, which results
from accumulation of lipid droplets in hepatocytes [5].
Efficient gene delivery in mammalian cells is another as-
pect of our review with appropriate choices of cell type
specific promoters and their use for targeted gene delivery
to hepatoma lines such as HepG2 and Hep3B. Nonethe-
less, the concept of gene transfer through plasmids started
in bacteria via both, physical and chemical methods. Simi-
lar approaches have been used in hepatoma cells and
other higher eukaryotes and mammalian cells and include
lipofection, DEAE-dextran, calcium-phosphate, viral vec-
tors, peptides and electroporation [6]. Lipofection has
been used to achieve transient as well as steady transfec-
tion in hepatoma cells resulting in an improved and stable
expression of transgenes even after several passages [7].
To develop protocols for cell type specific reporter acti-
vity, we discuss the use of alternate promoters and vectors
for stable expression in actively dividing cells.
Bioluminescent markers
Bioluminescence is the phenomenon of the production
of light by a chemical reaction within a living organism.
It was first discovered in firefly (Lampyridae species)
and since then has been used for various screening and
staining activities with an advantage of observing the
cells under a compound microscope. Firefly luciferase
(FLuc) emits luminescence (up to 560 nm) without the
requirement of any external light excitation and uses
ATP for the conversion of its substrate luciferin to oxylu-
ciferin in a luciferase enzyme catalyzed oxidation reaction.
Initially, FLuc was used only in luminometery based re-
porter assays using cellular lysates. Later luciferase ex-
pressing cells and mouse lines were developed for non-
invasive imaging of rodents. Injection of the luciferin sub-
strate in mice produces luminescent signals that can be
easily detected by in vivo imaging modalities. Apart from
beetle, luciferase has been isolated from members of the
coelenterazine species, i.e. Gaussia, Renilla, Pleuromamm
and Oplophorus. The luciferase from Renilla sp. (RLuc)
uses a different substrate “coelenterazine” and produces a
higher and stable luminescent signal as compared to the
FLuc [1]. RLuc has an added natural advantage of being
an ATP independent enzyme, and thus requires less en-
ergy to produce luminescence. However, a major limita-
tion of FLuc and RLuc is their short life span and
therefore these luminescent proteins cannot be used for
long duration imaging assays. This led to the developmentof a more photostable and robust luciferase in the form
of an enhanced beetle luciferase (ELuc) which again
uses luciferin as the substrate and is an ATP dependent
enzyme [8]. A comparison between ELuc and FLuc
showed phenomenal differences in the intensity and
photostability of the two luciferases. However, the Km
values (Michaelis constant) of the enzymes in regard to
ATP consumption were found to be almost equal, and it
was concluded that the ATP use is not the reason for a
better performance of Eluc. Moreover, ELuc was tested
in cell lines such as NIH/3T3 using various promoters,
and it was shown that the luciferase primarily localizes
in nucleus, cytosol and in peroxisomes. Certain vectors
and promoters also play an important role for their suit-
able expression namely pCMV vector used in mice cells
along with the astrocyte specific promoter mPer2 which
outperformed FLuc by a factor of 10- and 16-fold in cell
extracts and live cells, respectively [8].
Green fluorescent protein
In contrast to bioluminescence where the enzyme cata-
lyzed reaction initiates the excitation of luminescent
molecule, fluorescence is triggered when photons from
an external source excites the light absorbing pigments.
Green Fluorescent protein (GFP) was the first fluorescent
protein to be discovered in jelly fish (Aequorea victoria).
Wild type GFP (wtGFP) is a 26.9 kDa protein with a major
and a minor excitation peak (395 and 475 nm, respect-
ively) and a single emission peak at 509 nm. The chromo-
phore of this FP is formed by three amino acid residues
consisting of ser65-tyr66-gly67 and held by a single α-
helix surrounded by 11 β-barrel sheets to prevent its
quenching by water [8].
Several modifications have been made to wtGFP to en-
hance its fluorescence intensity as well as stability by
minimizing photobleaching. In the year 1995, Heim
et al. [9] introduced a single point mutation at the S65T
residue that resulted in enhanced fluorescence at the
same emission spectra but with a shift in excitation peak
from 395 nm to 488 nm. The mutation also significantly
reduced the time required for formation of the fluoro-
phore from 2 hours to 0.45 hours.
Several additional mutations in the protein helped the
molecule to fold optimally at 37°C while the protein ex-
pression was improved by codon optimization of the
wtGFP according to the host organism [10]. Additional
mutants were generated replacing the Serine65 with
threonine, alanine, glycine, cysteine or leucine leading to
a protein with a single absorbance peak at ~489 nm
[9-12]. Expression of GFP at high concentrations in the
cells posed the problem of dimerization which was re-
solved by side directed mutations at A206K, L221K or
F223R residues [13]. The enhanced GFP (EGFP) was de-
veloped with the modification and mutations described
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enhanced GFP can be visualized in cells with low light in-
tensities causing less photobleaching to enable imaging and
quantification of intracellular proteins and its pathways ef-
fectively [14-16]. To tackle the problem of mixed chromo-
phores in live cell imaging experiments, several mutants of
wtGFP including Enhanced GFP (EGFP) and Emrald GFP
were generated which retained its fluorescent properties
but with non-overlapping spectral properties [17].
Neutral chromophore GFP has also been generated
with a shift in the excitation and emission wavelengths
to UV and green light, respectively [12,18]. The proteins
were again mutated to create Sapphire which displays in-
creased emission at 37°C [10]. The new mutant of Sap-
phire called Turbo Sapphire has better pH-stability with
UV excitation and thus has a larger separation between
the excitation and emission wavelengths. Table 1 sum-
marizes the development of different variants of FPs and
their physical properties.
Several fluorescent proteins from different species have







Sapphire S72A, Y145F, T203I
T-Sapphire Q69M, C70V, V163A, S175G
Emerald F64L, S65T, S72A, N149K, M153T, I167T




EBFP BFP + F64L, S65T
EBFP 1.2 EBFP + S30R, Y36N, T65S, S72A, N105T, 117IV, N198S, A206
EBFP1.5 EBFP1.2 + F145H, H148N, M153A
EBFP2 EBFP1.2 + I128V, V150, D155V, V224R
Azurite EBFP + T65S, V150I, V224R
Sirius F46L, T65Q, W66F, Q69L, Y145G, H148S, and T203V, F223S
Cyan fluoresce
ECFP Y66W, F64L, S65T




Citrine S65G, V68L,S72A, T203Y, Q69M
Venus S65G, V68L,S72A, T203Y, F46L, M153T, V163A, S175G
Topaz S65G, S72A, T203Yspectra ranging from ultraviolet to far-red or infrared [10].
These have been used in several cells and organelles, and
some of them are discussed in this review.
Blue fluorescent proteins
Development of different variants of GFP with different
absorption and emission spectra provided the opportunity
for simultaneous multi-color staining of the cells. Early
variants included the blue fluorescent protein (BFP), de-
veloped by introducing a point mutation (Y66H) to shift
the absorbance and emission spectra to 384 nm and
448 nm, respectively, and cyan fluorescent protein (CFP)
which was discovered from mutants of A.victoria [17].
Since the spectra of BFP and EGFP are distinguishable, a
combination of these two FPs was first used for multi-
color imaging in cells and Fluorescent (Förster) Resonance
Energy Transfer (FRET) analysis [9,31,32]. However, a
major drawback of BFP was its low intensity and faster
photobleaching [33]. Therefore, enhanced BFP (EBFP)
was developed by using codon optimisation for human










488 509 ++++ 100 [19]
399 511 ++ [11]
399 511 ++ 78 [20]
487 509 +++ 116 [21]
, 485 510 +++ 160 [22]
nt protein
360 442 +
380 440 + 27 [16]
V 379 446 ++ 53 [23]
381 449 ++ 68 [23]
383 448 +++ 53 [23]
383 447 ++ 43 [24]
355 424 +++ 12 [25]
nt protein
433/445 475/503 ++ 39 [26]
433 475 +++ 79 [27]
433 474 ++ 45
ent protein
513 527 ++ 151 [28]
516 529 ++ 174 [29]
515 528 ++ 156 [30]
514 527 ++ 169 [21]
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photostable and brighter than the conventional BFP. EBFP
was generated by incorporation of two additional point
mutations (F64L and S65T) in the BFP and was consid-
ered to be the brightest BFP for the time until further im-
provements were made [24]. Subsequently, EBFP 1.2 was
developed based on mutations at S30R, Y39N, T65S,
S72A, N105T, I171V, N198S and A206V in EBFP and was
4-fold brighter than EBFP [23]. Further modifications of
EBFP 1.2 led to the development of EBFP 1.5 which was
more photostable than its predecessor EBFP 1.2 but with
no increase in fluorescence. Azurite, as previously men-
tioned, had increased photostability as compared to EBFP
1.2 and EBFP 1.5 due to the mutations at V150I and
V224R, respectively. However, this caused a decrease in
the fluorescence by 30% [24]. Screening of a library of mu-
tants generated by random mutagenesis identified EBFP2
with enhanced fluorescence and photostability when com-
pared to EBFP and Azurite. EBFP2 was reported to be 4-
fold brighter and 550-fold more photostable than EBFP
and 1.4-fold brighter and 2.9-fold more photostable than
Azurite [23]. However, both EBFP2 and Azurite tend to
dimerize when expressed in cells at higher concentrations.
This was overcome by replacing the alanine residue at
position 206 by valine [35]. BFP was further modified to
develop a stable red fluorescent protein (RFP). Site di-
rected and random mutagenesis of RFP generated
mTagBFP with a shift in excitation spectrum and blue
emission [36]. Although mTagBFP is the brightest among
all the BFPs produced, it is 1.4-fold less photostable than
EBFP2 [23]. Therefore, mTagBFP was mutated at I174A
to give rise to mTagBFP2, i.e. a 1.5 fold more photostable
BFP with a similar spectral profile and maturation half
time as that of the parent protein [37].
CFP and Yellow Fluorescent Protein (YFP) were devel-
oped as a multi-color pair. CFP was also brighter and
more photostable when compared to BFP [9] and was cre-
ated by a point mutation (Y66W) with a spectra inter-
mediate between BFP and EGFP. Further improvements
were also made to increase the stability and intensity of
CFP [18,32]. Mutation at T203 position of wild type GFP
with an aromatic amino acid resulted in shifting of excita-
tion and emission over 20 nm into yellow wavelength.
This led to the development of Enhanced Yellow FP
(EYFP). Although EYFP is a dimer and sensitive to chlor-
ine, three variants of EYFP were developed namely citrine
(monomer), Venus - a fast maturing FP at 37°C and the
yellow fluorescent protein for energy transfer (YPet) -
used in FRET along with cyan FPs [29,30,38].
Red fluorescent proteins
Red Fluorescent Protein (RFP) was first isolated from an
Anthozoan, Diascoma, with excitation and emission of
558 and 583 nm, respectively [39]. The major advantageof RFPs over GFPs is their longer excitation wavelength
causing less damage to the cells and much less auto
fluorescence in cells at the red spectrum. Also the mat-
uration of FPs obtained from anthozoan is more efficient
as compared to that of jelly fish FPs at 37°C. Native RFP
has the disadvantage of forming tetramers which at
times tends to aggregate in the cells and also cause false
oligomerization of target proteins to hinder their native
function [40]. DsRed, the common RFP available, has
prolonged maturation time often taking days to turn red
from a greenish complex; this feature has been used to
observe aggregate formation in target cells [41]. Mono-
meric RFPs have also been developed from DsRed
through a series of mutations, and the resultant proteins
exhibited different maturation rate as well as fluorescent
properties, i.e. mOrange, mKO, mStrawberry, mCherry,
Tag RFP, mPlum, mKate and tdTomato [42]. Due to its
fast maturation rate, high photostability and wide pH toler-
ance mCherry is a widely used long wavelength FP. How-
ever, it tends to dimerize that limits its experimental use.
Later the protein was modified to prevent its dimerization
in the cells. It is considered to be the brightest RFP with
enhanced photostability, and it has only a 3 nm longer ex-
citation and emission wavelengths compared to its prede-
cessors [43]. Similarly, Tag RFP was developed from
wtRFP isolated from sea anemone Entacmaea quadricolo
by introducing mutations at five different sites (R162E,
Q166D, S180N, F198V and F200Y) [44].
Fluorescent proteins and cell organelles
As of today, live cell imaging has advanced mainly due to
the advent of FPs tagged biomolecules with specific func-
tions in the cell. FPs have successfully been cloned into
bacteria to mammalian cell lines either alone as a marker
or along with a gene of interest as a fusion protein [45,46].
Several organic dyes have been tagged to cell organelles
to visualize the dynamics under a microscope, however,
not all dyes are readily accepted by the cell organelles and
in such conditions FP tagged proteins are used to target
the organelle. Multi-color live cell imaging is an effort to
observe multiple organelles, their spatial organisation,
interactions between organelles and their constituent
components. Therefore, the successful application of the
technique demands FPs and dyes with non-overlapping
emission spectra [47].
In recent developments organelle staining dyes such as
Hoechst 33342, MitoRed, DiOC6, SYTO 9 and rhoda-
mine B were tested along with several other dyes for im-
aging of various organelles in live cells and for the study
of host pathogen interactions [48]. In this regard, lipid
droplet staining has been done since a long time but
only with organic dyes such as oil red, and none of the
FPs mentioned earlier have been used for successful im-
aging of lipid droplets. The different fluorescent proteins
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cell are listed in Table 2.
Fluorogen activating proteins
Fluorogen activating proteins (FAP) are proteins/peptides
such as bovine serum albumin and IgG that can bind and
activate the fluorescence of target fluorogen molecules
and may also alter their spectral properties. Conjugation
of 9-(2-carboxy-2- cyanoviny1)julolidine (CCVJ) fluorogen
to either BSA and/or IgG not only improved its solubility
but also the fluorescence intensity by 6.3-fold when com-
pared to the unconjugated molecule [49]. The use of lar-
ger FPs such as GFP in reporter assays hinders the
function of the fusion proteins in the cells. Therefore,
small tag systems such as tetracysteine motif (CCXXCC)
were genetically inserted into the target proteins that can
bind with high specificity to biarsenical dyes, Resorufin
Arsenical Helix binder (ReAsH) and FIAsH (Fluorescein
Arsenical Helix binder) in live cells and lead to an en-
hanced fluorescent signal [50].
Of note, FlAsH, a derivative of 4’, 5’-bis (acetoxymercuri)
fluorescein, is a cell permeable non-toxic ligand that binds
specifically to four cysteine residues (I, i + 1, i + 4 and i + 5)
of the target proteins α helical structure to emit fluores-
cence [51]. Out of the fourteen different FlAsH ligands
screened, FlAsH-EDT2 showed strong affinity for hexamer
peptides and positive emission at 635 nm. FRET studies in
HeLa cells with FIAsH-EDT2 genetically fused to the
COOH-terminus of an enhanced cyan fluorescent protein
(ECFP-FIAsH) evidenced a 3-fold increase in fluorescence
at 635 nm when compared to the ECFP alone transfected
cells [32,51,52]. However, emission of ECFP at 480 nm de-
clined to about 30% in FIAsH-EDT2 transfected cells due
to FRET interactions. ReAsH-EDT2, a resorufin based
fluorescent complex with excitation and emission maxima
of 593 nm and 608 nm, respectively, was successfully tested
for FRET studies with GFP and YFP probe pairs in HeLa
cells [53]. Similar protein-ligand complexes were synthe-
sized and used namely CrAsH-EDT2, sFlAsH-EDT2,Table 2 Summary of fluorescent proteins used for various
cell organelle staining
Organelle Fluorescent proteins Reference
EGFP CFP Tag RFP mCherry DsRed
Nucleus Yes Yes Yes Yes Yes [10,31]
Mitochondria Yes Yes Yes Yes Yes [29,31]
Actin No Yes Yes Yes Yes [41]
Histones Yes Yes Yes Yes Yes [45,46]
Peroxisomes Yes Yes Yes Yes Yes [45,46]
Tubulin Yes Yes Yes Yes No [13]
Golgi Yes No Yes Yes No [15]
Endosomes Yes Yes Yes Yes Yes [45,46]F2FlAsH-EDT2, CHoXAsH-EDT2, SpLAsH-EDT2-
Alexa594, CaG FlAsH-EDT2 and AsCy3-EDT2. Several
modifications have been carried out to improve the
quantum yield, tetracysteine binding affinity and to reduce
the cytotoxicity of these complexes. Specifically, Mal-
achite green (MG) and Thiazole orange (TO) derived
intercalating FAPs were developed which bind to RNA
aptamer and DNA, respectively, and lead to enhanced
(2,360- and 550-fold, respectively) and bleaching stable
fluorescent signal from the fluorogens [54-56].
Several unique membrane permeant and impermeant
FAPs were developed by screening a library of human
single-chain antibodies (scFvs) using derivatives of thia-
zole orange and malachite green. The screened clones
have comparatively smaller size (the smallest being 110
amino acids long that is almost half the size of GFP) and
thousands-fold higher brightness as compared to the
typical FPs. Moreover, different spectral variants of MG
and TO could be easily generated by different combin-
ation of the screened fluorogens and FAPs. The fluores-
cence and differential interference contrast imaging
microscopy was performed in NIH3T3 cells with the
membrane impermeable (MG-11p) and membrane per-
meable (MG-ester) forms of MG fluorogens and FAP
HL4-MG scFv tagged to membrane protein platelet-
derived growth factor receptor (PDGFR). The MG-ester
signal was detected from the plasma membrane while
MG-11p emitting fluorescence inside the cells suggested
a localization near endoplasmic reticulum [54]. Figure 1
illustrates the uses of membrane permeable and imper-
meable MG FAP fluorogens and their application with a
fluorescent tagged protein to study trafficking of a
transmembrane protein.
Additionally, these FAPs were also tagged along with
GFP and other fluorescent proteins to study plasma
membrane and transporter proteins such as the insulin
regulated glucose transporter (GLUT4), β2 adrenergic
receptor (β2AR) and cystic fibrosis transmembrane con-
ductance regulator (CFTR). These genes were designed
such that the FAP and GFP were present as intracellular
and extracellular reporters and the fluorogens, being
membrane permeable and impermeable, were used to
observe the mobility and placement of the target pro-
teins tested in NIH3T3, C2C12 and HEK293 cells [57].
FAPs have been tested and proved to be reliable fluores-
cent markers for detecting and imaging various activities
in a cell like protein motility studies and even for trans-
membrane protein activity. FAPs provide wide scope in
developing alternatives to traditional fluorescent proteins
where size hinders the activity of the target proteins.
Vectors for transient and stable transfection in cell lines
Bacterial transformations have led to the expression of
various genes in the prokaryotic system with certain
Figure 1 Live cell imaging with fluorogen activating proteins (FAP). Malachite green (MG), an organic dye and its membrane permeable
(MG-Ester) as well as the membrane impermeable variants (MG-11P) are used in FAP imaging. Essentially, the FAP system consists of an encoded
protein such as a single chain antibody fragments to activate the fluorescent dye and/or its derivatives. Note, initially MG was used to visualize
RNA aptamers. The intracellular trafficking of the membrane bound receptor tyrosine kinase PDGFR is given as an example. Similarly, membrane
bound proteins tagged with both FAP and fluorescent proteins like blue fluorescent proteins are useful in studying the protein positioning across
the membrane [54].
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the transfer of genes in the mammalian cells requires much
more sensitive approaches, and several methods have been
developed for effective transfer and stable expression of
genes in these cells. With the advent of viral vectors much
progress has been made in the field of gene transfer.
Promoters for hepatic cell lines
Expression of a foreign gene inside a cell greatly relies
on the choice of the vector, mode of transfection (stable
vs. transient) and type of promoter used (constitutive vs.
cell-specific and inducible vs. non-inducible). The choice
is made based on the experimental requirements, cell type
and the technical expertise. To achieve stable transfection,
integration of transfected genes in the host genome is
desirable. The transient expression vectors reside in the
cytosol without replicating and therefore the genes of
interest are expressed for a limited period of time. In
contrast, stable transfection vectors facilitate the inte-
gration of the transgene in the host cell genome and
therefore, it is replicated and subsequently inherited.
The introduction of a selection marker (antibiotic re-
sistance gene) in the expression cassette allows the dif-
ferentiation and expansion of the stable transfected
population from the non-transfected cells.The use of cell type specific promoters allows greater
control over the expression of foreign genes. Liver cell
specific promoters such as Glycerol-3-Phosphate Acyl-
transferase (GPAT I and GPAT II) and phosphoglycerate
kinase 1 (pgk-1), albumin, human alpha1-antitrypsin and
hemopexin are shown to be active in hepatocytes of hu-
man and mice origin [7,58,59]. Similarly, viral promoters
and vectors have been tested in different cell lines for
their specificity and stability of expression. pCNS and
pCNS-D2 vectors were reported to express cloned genes
in cell lines and can also act as a shuttle vector between
bacteria and mammalian cell lines to facilitate an easy
cloning process. This vector system has been tested for
stable expression of luciferase in HepG2, Hep3B, HeLa,
SNU638 and SNU668 cell lines. The luciferase expres-
sion was higher in HepG2 and SNU638 cells as com-
pared to other cell lines.
Cytomegalovirus (CMV) and Simian virus 40 are
known to infect human and other primate cells and have
been shown to induce a stable expression of transgene
in various cell lines [60]. During the study of CMV pro-
moter systems, a 5’ Untranslated Region (5’ UTR) was
identified which was shown to boost the expression of
viral proteins facilitating the rapid propagation of viral
particles in the host cell. Incorporation of UTR regions
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of genes of interest in host cells such as CHO or HepG2.
Notably, the use of two copies of the UTR regions further
improved the expression of target genes in actively divi-
ding cells [61].
Later, the UTR regions were found to be the Internal
Ribosome Entry Sequence (IRES) being responsible for
uninterrupted expression of genes. IRES were first discov-
ered in RNA of Poliovirus in 1988 by Pelletier and Sonen-
berg [61] and facilitate the viral replication machinery by
providing means for viral RNA to bind with the 40s sub-
unit of the host ribosomal complex thus eliminating the
need for eukaryotic translation factors [62,63]. Since then,
several viral vectors have been developed including the re-
cently explored corona virus of the SARS virus family.
This RNA based vector provides a stable and prolonged
expression for more than 30 passages in different cell
types [62]. Insertion of IRES site in expression vectors also
offers the possibility of separate expression of the cloned
genes under a single promoter (Figure 2) [61]. Table 3
summarizes the list of various promoters and plasmids
that have been used extensively in mammalian cell lines.Figure 2 Schematic overview of gene transfer methods for live cell im
expression of fluorophore tagged proteins, (A) Transient and stable express
lipofection. The later is the most frequently used method for gene transfer
transfection efficiency have been used for special cell lines. (B) Recombinan
under a common promoter (P) in host cells. Incorporation of a selection m
expression of the cloned genes. Upon excitation with specific wavelength,
provides the information on localization and probable interactions of the t
Cell organelles or structures can be stained using synthetic dyes such as O
target protein encoding gene and protein, FP: fluorescent protein encodinAmong all promoters used CMV and SV 40 are most
efficient in a wide range of cell lines. Apart from these
cell specific promoters such as pgk1 and GPAT enhance
expression levels in hepatoma cell lines.
Modes of gene transfer in cells
A variety of methods have been developed for a robust
and efficient gene transfer without causing toxicity to
the host cell.
Earlier physical methods such as electroporation and
microinjections [64,65] were primarily used for gene
transfer studies but have been sidelined gradually due
to the obvious disadvantages of being time consuming
and the associated technical difficulties. More advanced
methods have come into place for gene transfer according
to the need for expression as a plasmid entity or as an in-
tegrated system in genome which also can be used for
gene knockouts.
Viral vectors
Non-pathogenic viral vectors are commonly used for gene
transfer studies. Baculovirus of the Autographa californicaaging studies. Depicted are methods for gene delivery and
ions of genes using viral or synthetic vectors, microinjection and
. Bacterial vectors of Listeria and Salmonella sp although hurdled by low
t plasmid expressing fusion protein (target protein and fluorophore)
arker (SM) in the plasmid provides opportunity for controlled
the fluorescence images are captured using appropriate filters. This
arget protein with different cell organelles and/or other biomolecules.
il Red O for intracellular staining of lipid droplets. P: promoter, TP:
g gene and protein, LD: lipid droplet stained with Oil Red O.
Table 3 Promoters and vectors used for stable/transient expression in mammalian cells
Expression in cell line
Vector Promoter HepG2 Hep3B CHO HeLa 3 T3 Reference
pCNS/pCNS-D2 hCMV/T7 nil stable/transient nil stable nil [60]
pGL3 GPAT stable stable nil nil nil
pLR/IRES RSV nil nil nil nil nil [62,63]
pSV2βCat SV2 stable/transient nil stable/transient stable/transient stable/transient [60]
PCMVβcat CMV stable/transient nil stable/transient stable/transient stable/transient [60]
Puast SV 40 expressed genes in yeast [60]
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byx mori nucleopolyhedrovirus (BmNPV) genus provide a
safe and efficient means of gene delivery to target cells
[66]. Baculoviral vectors have been modified to infect
mammalian cell lines either as the whole baculovirus or as
a helper cell mediated gene delivery in cells. Adenovirus
terminal repeats were used for the replication of the target
gene, and the whole plasmid was packed into the baculo-
viral vector Bac-B4 for transfer in cell lines such as
293B5B1. The transfected cells showed not only stable ex-
pression but also a 100-fold increase in the vector titer
during subsequent passages [67]. Of note, DNA fragments
of approximately 38 kb were efficiently transferred into
different cell lines using such a vector. Direct incubation
of oligodendrite and chicken muscle cells with baculoviral
vector showed a transfection efficiency of 60% [68]. Fur-
ther increase in transfection and expression efficiency was
achieved by additional modifications in baculoviral vectors
such as an introduction of the metallothione promoter
(Bac-ME). The Bac-ME vector showed a transfection effi-
ciency of 90% with low leaky expression and reduced cyto-
toxicity in HeLa cells. The expression efficiency of these
vectors was further enhanced by treating the transfected
cells with ZnSO4 [69].
Although the baculoviral vectors were successfully
used for gene transfer experiments in several mamma-
lian cell lines they were replaced by other viral vectors
and methods due to the associated cytotoxicity specific-
ally at higher cell to virus ratio. Hence, non-viral vectors
were developed for transfection of viral sensitive mam-
malian cell lines [70].
Bacterial based methods
Bacterial based transfection has also been employed by
cloning sequences belonging to the pathogenic bacteria
E.coli. The modified genes from pathogenic bacteria like
Listeria monocytogenes have also been used where the
bacteria with its intracytoplasmic capabilities propagate
into the host. Likewise, E.coli was modified so that self-
lysis genes become activated as soon as the bacteria
enter the host cell to release the vector into host cyto-
plasm [70].Other bacterial methods involve T4SS, a Bartonella
sp., for the introduction of single strand DNA into the
host cell. Thus, after entry the bacteria releases ssDNA
into cytosol and along with the enzyme relaxase or inte-
grase, which is bound to target DNA, starts to replicate
to finally produce plasmid DNA as a whole by joining
the loose ends present [70]. This mode of transfer is
considered to be hazard free and is employed for a var-
iety of cell lines.
Further methods of nonviral based gene transfer have
been developed for higher efficiency and less toxicity to
the cells. As mentioned earlier for efficient transfection
the gene has to be integrated into the genome (constitu-
tively) or is continuously expressed in the presence of a
specific inducer reagent for the chosen promoter (indu-
cible). Owing to variable results the need remains to de-
velop efficient methods as has been attempted in the
form of a dual plasmid approach using the mice myo-
genic C2C12 cell line. According to this method T-Rex
plasmid system is first transfected into the cell line using
a lipid based method with an efficiency of 70% and is ac-
tivated by tetracycline. Thereafter, a modified T-Rex
plasmid became available. After 18 days of initial trans-
fection a second plasmid can be introduced with 40% ef-
ficiency that permits the study of complex biochemical
reactions involving different factors [71].
In Table 4 the various transfection efficiencies of
different methods are summarized. Bactofection seems
to be an effective mode of transfection in cells with-
out the risk of cytotoxicity as compared to some viral
methods but much improvement has to be made for
application of bactofection for a wide variety of cell
lines.
Lipofection
Lipofection involves formation of a positively charged
lipid-nucleic acid complex by suspending negatively
charged DNA/RNA molecules with cationic lipids for a
short duration of time. The positive charge on the com-
plex facilitates attachment to the cell membrane and
entry via endocytosis [70]. A comparative study con-
cluded that lipofection is the safest method to transfer
Table 4 Summary of transfection efficiency in different cell lines through various methods
Transfection efficiency
Transfection method HepG2 Hep3B CHO HeLa 3 T3 Reference
Baculovirus 60-90% 60-90% 60-90% 60-90% 60-90% [58,68-70]
Baculovirus mediated adenoviral vector - - 40-50% 55-60% - [67]
Lipofection 40-60% 40-60% 60-70% 60-70% 50-60% [72]
Cationic lipids 47-60% 45-55% 65% 60% - [73,74]
Non-viral - - - 60% - [71,75]
E.coli (modified Salmonells/Listeris sp.) - - - 50% - [70]
T4SS (Bartonella sp.) - - - 50% - [70]
T4SS (Bartonella sp.) 60-70% 50% >70% >60% 50-60% [76-78]
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methods [70]. Different commercially available kits with a
broad range of efficiency on different cell lines are available.
The transfection efficiency of methods varies depending
upon the cell type, cell number and ratio of DNA and re-
agent used. Using lipofection and as determined with a
GFP marker an efficiency of about 60% was obtained in
CHO-K1 cell lines [72].
Lysomotropic agents
The major challenge faced by most of the non-viral de-
livery systems is the degradation of the transfected nu-
cleic acid in the endosomes and/or lysosomes as they
are mainly internalized by endocytosis. Lysosomotropic
agents like chloroquine and polyvinylpyrolidone (PVP)
have been used effectively to increase the transfection ef-
ficiency of different delivery methods by reducing the
lysosomic degradation of the transfected nucleic acid
[73,79-83]. However, the cytotoxicity of these agents
raises concerns against their use. Chloroquine is known
to increase the intracellular pH leading to cytotoxicity
and degradation of transfected DNA at higher concen-
trations and at prolonged exposure times (>4 hours).
Amongst the two variants of PVP, PVP10 was reported
to be cytotoxic at all concentrations while PVP40
showed negligible cell toxicity and even improved the
transfection efficiency. PVP40 has been used for trans-
fection studies in macrophages and hepatocytes [84]. Su-
crose is also known to cause intracellular swelling of
vesicles in endosome and lysosomes due to osmotic
pressure [85,86]. Sucrose in conjunction with lipid-DNA
complex or lipofection reagents was shown to increase
their transfection efficiency in fibroblast cell. Further-
more, no toxicity has been reported using sucrose as
lysosomotropic agent and a concentration range of 5 to
500 mM was safe in various cell lines such as CHO,
COS7 and HEK 293 T cells.
Beneficial effects of these lysosomotropic agents were
compared against Lipofectamine 2000 in COS7, CHO and
HEK 293 cell lines. Essentially, the transfection efficiencyof lipofectamine was increased by 6- and 3-fold when used
in conjunction with PV40 and sucrose, respectively.
Chloroquine, although being toxic showed an increase of 3-
to 6-fold when used at a concentration range of 0.01 to
0.1 mM as compared to lipofectamine alone [87].
Poly(ethyleneimine) is another cationic polymer trans-
fection reagent frequently used in a variety of cell lines.
However high cytotoxicity is the major drawback associ-
ated with PEI and therefore several changes in its molecu-
lar structure have been done to reduce its cytotoxicity and
this includes PEGylation and the introduction of carbohy-
drate, lipid and peptide moieties [75,88-90]. A recent
study showed the improved transfection efficiency and
low cytotoxicity of an anionic glycopolymer derivative of
PEI in HepG2 and HEK 293 T cells [91].
Modified lipids
Modified lipids were developed to enhance the transfec-
tion efficiency of vectors. Specifically, cationic oligopep-
tide lipids are charged lipids with a linker molecule to
provide cations and are said to be more efficient in the
presence of the serum containing medium [74]. Different
ratios of nucleic acid and lipids were tested ranging from
1:1 to 9:1 and the ratio of 3:1 was found to be optimum
in terms of cell viability and transfection efficiency [74].
Other synthetic vectors have been tested for gene trans-
fer in various cell lines. Polyspermine Imidazole-4, 5-
amide complex (PSIA) was employed with HepG2 as
well as Cos 7 cell lines for gene targeted therapy. PSIA
transfection efficiency is of only 20-30% in HepG2. Apart
from the risk of PSIA degradation that hinders complex
formation with plasmid DNA the process of PSIA synthe-
sis requires strict environmental (pH and temperature)
conditions before DNA can be introduced [92].
Hepatocyte/hepatoma cells specific transfection
To improve transfection efficiency in various hepatoma
cell lines like Huh-7, HepG2 and Hep3B different strat-
egies were employed including lipofection, electroporation
and microinjection. Microinjection (100 μg/ml) and
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plasmid encoding fluorescent protein (pEGFP and pEYFP)
tagged to human and mouse ADRP genes in Huh-7 cells as
to study the pathways of lipid droplet metabolism. A trans-
fection efficiency of 66% was achieved, and none of the
methods affected the expression or the interaction of pro-
teins in cells proving their reliability and safety. However,
the transfection efficiency of these methods varied inversely
with the size of the plasmid [93]. In this regard, adenoviral
vectors have been employed in HepG2 cells to study the
function of genes such as the cytochrome P450 monooxy-
genases in drug induced hepatotoxicity. Notably, CYP1A2,
CYP2D6, CYP2C9, CYP2C19 and CYP3A4 were trans-
fected in HepG2 cells using recombinant adenoviral vector
with a transfection efficiency of approximately 70% [94,95].
In most cases transfection or transduction of primary
cells proof to be difficult for several reasons like the
stable state of non-dividing or quiescent cells. However,
some viral vector-based methods have been used suc-
cessfully such as the murine retroviral vector that can
transfect primary hepatocytes stimulated by mitogens
(epidermal or hepatocyte or keratinocyte growth fac-
tors). Moreover, the associated high costs and varying ef-
ficiency of the growth factors make these transfection
methods unfavorable [96-99]. Lentiviral vectors are cap-
able of transfecting quiescent cells [100-102] and haveFigure 3 Oil red O staining for imaging and quantification of lipid dropl
cells treated with fatty acid, amiodarone and/or TNF-α. (B) Spectrophoto
load in hepatocytes treated with fatty acids and/or amiodarone. (C) MTT assa
cultured hepatocytes.been successfully used for gene transfer experiments in
various hepatoma cell lines [76,103,104].
Although the discussed methods and markers are com-
patible with various if not all cell lines, the cell lines
chosen have to be noted to select the right kind of vector
and promoter system. An overview of the various trans-
fection methods in different cell lines is given in Figure 2.
Lipid droplet staining
Research in recent years significantly advanced an un-
derstanding of the molecular causes of fatty liver disease,
and live cell imaging of hepatoma cells proved to be ex-
tremely valuable for studying lipid droplet formation.
Lipids are primarily stored in adipocytes as lipid drop-
lets; however, under stressed conditions hepatocytes can
also produce lipid droplets leading to pathological condi-
tions like fatty liver disease [105,106]. Lipid droplet
staining requires cell permeable dyes/fluorochromes
which can bind specifically to the components of the
lipid monolayer of droplets. The most commonly used
dyes for lipid staining are Oil Red O, Nile Red and BOD-
IPY with an excitation-emission spectrum in the range
of 400–500 nm and 500–600 nm, respectively. Figure 3
depicts Oil red O staining of lipid droplets in cultured
human hepatocytes treated with palmitic acid (PA) and
oleic acid (OA) and the cardiovascular drug amiodaroneets in hepatocytes. (A) Oil red O staining of lipid droplets in hepatic
metric quantification of Oil red O stain to determine intracellular lipid
y to determine cytotoxic effect of fatty acids, and/or amiodarone on
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patients.
FPs and dyes with non-overlapping fluorescence
spectrum are required for differential staining of multiple
biological molecules involved in lipid droplet metabolism.
To address this issue, a long wavelength FP and a short
range dye Monodansyl Pentane (MDH) was developed for
lipid droplet staining with excitation and emission in the
range of 405 and 480 nm [106]. Such an approach allowed
the study of perlipin 2 interactions on the lipid droplet as
defined by the MDH stain. Notably, in the early works of
Niemann et al. (2001) the use of MDH as a mean to study
lipid droplets was reported [107]. MDH was also found to
be photostable when compared to Nile red and BODIPY
with a light emission of more than 15 minutes wherein the
latter dyes were stable up to 10 minutes only [106]. MDH
has a potential use for lipid droplet staining to facilitate an
understanding of the formation of lipid droplets and their
interaction with various proteins within hepatocytes.
The lipid droplet monolayer has many associated pro-
teins namely Adipocyte Differentiation-Related Proteins
(ADRP also known as perilipin 2/plin2) and Perilipins
(Plins) which interact with other organelles in the cell.
Simultaneous detection of lipid droplets and ADRP was
achieved by transfecting HuH-7 cells with ADRP-GFP
encoding plasmid and staining of lipid droplets with Oil
red O. Although this method was useful in observing
the cytoplasmic interaction of ADRP/plin2 with lipid
droplets the precise localization of GFP-ADRP/plin2 at
the surface of lipid droplet was distinctly observed only
after incubating the cells with BODIPY558/568 dodeca-
noic acid, a fatty acid sequestered in lipid droplets as ev-
idenced by imaging by confocal microscopy in live and
fixed cells conditions [93]. While this study was one of
the first reports on lipid-protein interactions investi-
gated by live cell imaging the use of BODIPY hindered
clear imaging due to background signals. To overcome
these obstacles FRET and FRAP methods were used as a
means to study these complexes.
Moreover, MDH stain provides an efficient stain for
lipid droplets which allows proteins to interact with the
droplets to be tagged with longer wavelength fluorescent
proteins and also MDH provides a more stable and ro-
bust stain for lipid droplets as compared to the trad-
itionally used Oil red O and Nile red stains.
Lipid droplet-protein interaction in FRET and FRAP
studies
FRET studies
FRET is an approach to study protein-protein interaction
and co-localization of organelles on the principle of energy
transfer between two chromophores situated in close
proximity (6–10 nm). The pair of fluorescent probes used
has an overlapping spectral profile, and the emissionwavelength of the donor probe (GFP) provides the re-
quired energy for the excitation of the acceptor probe
(CFP). Acceptor bleaching can be used to demonstrate
whether the organelles are within the FRET-distance (i.e.
6–10 nm), thus demonstrating true association on a mo-
lecular scale. FRET was used to observe motility of certain
proteins as well as organelles [108].
Notably, laser scanning confocal microscopy based FRET
assays have been employed to study the co-localization
of lipid droplets and mitochondria in porcine oocytes
using the Mitotracker Green (MTG) and Nile Red (NR)
fluorochromes. FRET acceptor bleaching methods have
also been used to examine mitochondria-lipid droplet
co-localization [109].
To study protein-lipid interactions on the surface of
the lipid droplets, perilipin 2 was tagged with CFP and
followed by cyan fluorescence. Since it forms a strong
FRET interaction with the lipid stain 22-(N-(7-nitro-
benz-2-oxa-1, 3-diazo) aminostearic acid (NBD), the co-
localized protein-lipid gave a signal of yellow-to-orange.
The mouse perilipin 2 gene was cloned into the mamma-
lian expression vector pECFPN1 and was stably expressed
in mouse L fibroblast cells. Subsequently, NBD was used to
stain phosphatidyl choline to form NBD-PC complex, and
a confocal microscopy based FRET assay was employed
to determine the interaction between lipids and proteins
in the cell. Similarly, co-localization of perilipin 2 and
sphingomyelin (SM) near plasma membrane was dem-
onstrated using NBD-SM and plin2-CFP vector con-
structs [110]. Although CFP and YFP are most widely
used probes YFP has the disadvantage of having low
quantum yield and poor signal to noise ratio hampering
the process of individual CFP intensity measurement.
To counter this problem, two ECFP molecules were
fused; however, the result was a further decrease in the
intensity due to multiple excited states causing inter-
conversion of excited states by homotransfer. Notably,
multiple excited states are due to two different crystal
structure conformations of ECFP [111]. This problem
was resolved by site directed mutagenesis of the His148
residue to aspartate, and the fluorescence intensity of
the mutant was further increased by a factor of 2.5 as
compared to ECFP. Further mutations at S72A and
Y145A residues boosted the extinction coefficient of the
monomer but caused a decrease in the quantum yield.
The modified ECFP is known as Cerulean and is proved
to be a better FRET donor than the conventional ECFP
[111]. Figure 4 depicts a basic understanding on how
FRET analysis can be done using ECFP and EYFP par-
ticularly for lipid droplet studies.
FRAP studies
Fluorescent Recovery After Photobleaching (FRAP) is
used to study single membrane bound structures, single
Figure 4 FRET studies to determine interaction between plin5
and the ATGL protein on lipid droplet in adipocytes [39]. Plin5
(1) and ATGL (2) proteins were tagged with FRET probes CFP (3) and
YFP (4), respectively. The emission spectra of CFP act as excitation
wavelength for the YFP. Detection of yellow fluorescence after
activation of CFP (436 nm) suggest possible interaction of the two
tagged proteins.
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of activating a fluorescent protein observing its intensity
and subsequent bleaching by excess light to finally meas-
ure the bleached region for binding activity to the surface
of the secondary structure or membrane. CFP and YFP
have been commonly used to study the interactions of
perilipin 1 (plin1) and perilipin 5 (plin5) with Adipocyte
Triglyceride Lipase (ATGL) and its corresponding activa-
tor α-β-hydrolase domain-containing 5 (Abhd5). On the
basis of FRAP studies in COS 7 cells, it was concluded
that plin5 interacts with ATGL but not plin1 [27].
ADRP/plin2 is shown to be located at the surface of
cytoplasmic lipid droplets [112], and localization studies
for DNA fragments encoding human and mouse ADRP
were ligated in-frame to the 3’ end of EGFP, thereby gen-
erating GFP-hADRP (expressed by plasmid pLA4) and
GFP-mADRP fusion products. To examine whether the
GFP-ADRP products for both species retained the capacityto associate with these structures, constructs expressing the
fusion proteins were transfected in HuH-7 cells. After
stimulation with fatty acid, the formation of lipid drop-
lets in HuH-7 cells can be identified by staining with
lipophilic dyes and by antisera raised against ADRP/
plin2. The signal from GFP-mADRP was detected from
the surface of spherical intracellular structures while
EGFP was seen throughout the HuH-7 cells. The loca-
lization of endogenous hADRP and the GFP-mADRP
products coincided, indicating that GFP-mADRP was lo-
cated at the surface of lipid droplets therefore demonstrat-
ing that it is possible to detect tagged and untagged ADRP
on the same lipid droplet. To verify the localization of
GFP-mADRP, cells expressing the fusion protein were in-
cubated with BODIPY 558/568 dodecanoic acid, a fluo-
rescent fatty acid analogue that is sequestered in lipid
droplets. The dye was selected because of its spectral
properties which allow differentiation from EGFP and a
better cell permeability as compared to Oil red O. Results
in both live cells and paraformaldehyde fixed cells showed
localization of GFP-mADRP at the surface of lipid drop-
lets stained with the BODIPY dye. Attempts to fuse EGFP
to the C terminus of ADRP/plin2 yielded few cells that
produced fluorescence of the chimeric protein but in this
case the signal did not derive from the surface of lipid
droplet. Consequently, EGFP fused to the N terminus of
human and mouse forms of ADRP/plin2 was used in fur-
ther studies [93].
It is well recognized that caveolins are found on lipid
droplets, but the functional significance of this associ-
ation is poorly understood. Adenovirus mediated trans-
fer of Cav1-GFP in NIH3T3 cells demonstrated that
caveolin-1-coated lipid droplets can grow larger than
caveolin-1 devoid lipid bodies suggesting the importance
of caveolins in determining the size of lipid droplets.
This study provided the first detailed characterization of
the impact of caveolins on molecular composition and
the size of lipid droplets [113].
Proximity ligation assay
The most frequently employed tools (ELISA, Western
Blot, FRET, FRAP co-immunoprecipitation) to study pro-
tein expression or protein-protein interactions rely on the
use of antibodies tagged with either fluorophores or en-
zymes. The sensitivity of these techniques differs signifi-
cantly, and the detection of proteins at low expression
levels still remains challenging. The proximity ligation
assay is a relatively inexpensive quantitative technique
with high sensitivity. The technique is developed on the
principles of antibody targeted assay, split reporter assay
and polymerase based amplification of oligonucleotides.
In this assay, the target proteins are recognized by specific
antibodies (two or more) conjugated with short oligo-
nucleotide strand. In case these probes are in near
Figure 5 In situ proximity ligation assay. (1) Recognition and binding of oligonucleotide labeled antibodies to interacting target proteins.
(2) Formation of covalently joined circular oligonucleotide by ligase reaction: If the two probes are in close proximity, addition of two linear
oligonucleotide leads to the formation of a covalently joined circular oligonucleotide molecule with the help of a ligase enzyme. (3) Amplification
via Rolling circle mechanism: One of the probes linked to antibody act as a primer and addition of DNA polymerase yields long single stranded
concatemeric DNA molecule composed of complements of the circular DNA strands formed in the ligase reaction. (4) Fluorophore labeling for
detection: The amplified product is easily detected by addition of complementary oligonucleotides labeled with fluorophore.
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of complementary oligonucleotide and ligase enzyme and
subsequently amplified using PCR or rolling circle amplifi-
cation. This leads to the formation of more than 1000 cop-
ies of the complement of 100 bp in one hour using the
phi29 polymerase [114]. The incorporation of multiple fluo-
rescently labeled oligonucleotides in the polymerase cata-
lyzed reaction causes amplification of the signal resulting in
high sensitivity. Apart from protein expression and protein-
protein interaction, this highly versatile technique can also
be adapted to detect post-translational modifications, co-
localization and interaction of proteins with other biomole-
cules (Figure 5). PLA was recently used to demonstrate that
the MYC inhibitor 10058-F4 could prevent MYCN/Max
interaction in situ and caused accumulation of lipid drop-
lets in tumor cells [115].
Concluding remarks
The availability of a wide range of fluorescent proteins and
organelle specific stains provides unprecedented oppor-
tunities for microscopic studies of diverse cellular processes
including protein-protein interactions. However, for the
visualization of certain cell components in live cells such
as lipid droplets options are currently limited to organic
dyes, i.e. BODIPY, Nile red and Oil red O. The emission
spectrum of these dyes overlaps with that of GFP andRFP; thus, it is not feasible to use them in combination for
multi-color imaging. There is unmet need for the develop-
ment of a new lipophilic dye which can be spectrally resolved
from commonly used fluorophores. Monodansylpentane, a
cadaverin family dye with blue emission spectra, is the ap-
propriate substitute for the red dyes for lipid staining. Fur-
thermore, this can be used along with far wavelength
fluorescent proteins to obtain better insight into the lipid
metabolism. Discovery of novel proteins involved in the
lipid droplet metabolism and their fusion with fluorescent
proteins that can be spectrally resolved will help re-
searchers to delineate the process of biogenesis of lipid
droplets under live cell conditions. The advancements in
culture systems to ensure long term metabolic activity of
hepatocytes, the development of suitable transfection
methods and reporter assays will be instrumental for the
success of live cell imaging experiments.
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